Randomized controlled trial for selective preventive transdiagnostic intervention for adolescents at risk for emotional disorders

Manuel Vivas-Fernandez, Luis-Joaquin Garcia-Lopez, Jose A Piqueras, Jose-Antonio Muela-Martinez, Josefa Canals-Sans, Lourdes Espinosa-Fernandez, David Jimenez-Vazquez, Maria Del Mar Diaz-Castela, Paula Morales-Hidalgo, Maria Rivera, Jill Ehrenreich-May, Manuel Vivas-Fernandez, Luis-Joaquin Garcia-Lopez, Jose A Piqueras, Jose-Antonio Muela-Martinez, Josefa Canals-Sans, Lourdes Espinosa-Fernandez, David Jimenez-Vazquez, Maria Del Mar Diaz-Castela, Paula Morales-Hidalgo, Maria Rivera, Jill Ehrenreich-May

Abstract

Significant evidence does exist on the effectiveness of transdiagnostic interventions to improve emotional problems in clinical populations, and their application as universal and indicated prevention programs. However, no randomized controlled trials (RCT) studying selective transdiagnostic prevention intervention have been published. This is the first known RCT to evaluate the efficacy/effectiveness of an evidence-based selective prevention transdiagnostic program for emotional problems in adolescents. The impact of three different interventions was evaluated: (1) PROCARE (Preventive transdiagnostic intervention for Adolescents at Risk for Emotional disorders), which is a group-based, abbreviated version of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Adolescents (UP-A), along with adding a booster session to reduce risk of onset of anxiety and depression, (2) PROCARE + , which includes the PROCARE protocol along with personalized add-on modules tailored to match adolescents' risk factors, and (3) an active control condition (ACC) based on emotional psychoeducation. In total, 208 adolescents (48.5% girls) evidencing high risk and low protective factors were randomized and allocated to PROCARE, PROCARE + or ACC. Data from 153 adolescents who completed all assessments in the different phases of the study were analyzed. Self- and parent-reported measures were taken at baseline, as well as after the intervention, a 6 month follow-up was carried out, together with a 1 month follow-up after the booster session. Differences between conditions were significant on most of the outcome measures, with superior effect sizes for PROCARE + in the short and long term. Interventions were acceptable in terms of acceptability, with good satisfaction rates. Tailored targeted selective transdiagnostic interventions focused on mitigating risk factors and promoting protective factors in vulnerable adolescents are promising.

Keywords: Adolescence; Anxiety; Depression; Randomized control trial; Selective prevention; Transdiagnostic.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2023. The Author(s).

Figures

Fig. 1
Fig. 1
Consort flow diagram

References

    1. Ahola P, Joensuu M, Knekt P, Lindfors O, Saarinen P, Tolmunen T, Lehtonen J. Effects of scheduled waiting for psychotherapy in patients with major depression. J Nerv Mental Dis. 2017;205(8):611–617. doi: 10.1097/NMD.0000000000000616.
    1. Ahorsu DK, Lin CY, Imani V, Saffari M, Griffiths MD, Pakpour AH. The fear of COVID-19 scale: development and initial validation. Int J Mental Health Addit. 2020 doi: 10.1007/s11469-020-00270-8.
    1. Alonso J, Liu Z, Evans-Lacko S, Sadikova E, Sampson N, Chatterji S, Abdulmalik J, Aguilar-Gaxiola S, Al-Hamzawi A, Andrade LH, Bruffaerts R, Cardoso G, Cia A, Florescu S, de Girolamo G, Gureje O, Haro JM, He Y, de Jonge P, Karam EG. Treatment gap for anxiety disorders is global: results of the world mental health surveys in 21 countries. Depress Anxiety. 2018 doi: 10.1002/da.22711.
    1. American Psychological Association (2017). Ethical principles of psychologists and code of conduct. American Psychological Association. .
    1. Anniko MK, Boersma K, Tillfors M. Sources of stress and worry in the development of stress-related mental health problems: a longitudinal investigation from early- to mid-adolescence. Anxiety Stress Coping. 2019;32(2):155–167. doi: 10.1080/10615806.2018.1549657.
    1. Axelson DA, Birmaher B. Relation between anxiety and depressive disorders in childhood and adolescence. Depress Anxiety. 2001;14(2):67–78. doi: 10.1002/da.1048.
    1. Balázs J, Miklósi M, Keresztény Á, Hoven CW, Carli V, Wasserman C, Wasserman D. Adolescent subthreshold-depression and anxiety: Psychopathology, functional impairment and increased suicide risk. J Child Psychol Psychiatry. 2013;54(6):670–677. doi: 10.1111/jcpp.12016.
    1. Barlow DH, Allen LB, Choate ML. Toward a unified treatment for emotional disorders—republished article. Behav Ther. 2016;47(6):838–853. doi: 10.1016/j.beth.2016.11.005.
    1. Barriuso-Lapresa LM, Hernando-Arizaleta L, Rajmil L. Reference values of the strengths and difficulties questionnaire (SDQ) version for parents in the Spanish population, 2006. Actas españolas de psiquiatria. 2014;42(2):43–48.
    1. Beesdo K, Knappe S, Pine DS. Anxiety and anxiety disorders in children and adolescents: developmental issues and implications for DSM-V. Psychiatric Clin. 2009;32(3):483–524. doi: 10.1016/j.psc.2009.06.002.
    1. Bennett K, Manassis K, Duda S, Bagnell A, Bernstein GA, Garland EJ, Miller LD, Newton A, Thabane L, Wilansky P. Preventing child and adolescent anxiety disorders: overview of systematic reviews. Depress Anxiety. 2015;32(12):909–918. doi: 10.1002/da.22400.
    1. Bentley KH, Boettcher H, Bullis JR, Carl JR, Conklin LR, Sauer-Zavala S, Pierre-Louis C, Farchione TJ, Barlow DH. Development of a single-session, transdiagnostic preventive intervention for young adults at risk for emotional disorders. Behav Modif. 2018;42(5):781–805. doi: 10.1177/0145445517734354.
    1. Bolinski F, Kleiboer A, Karyotaki E, Bosmans JE, Zarski AC, Weisel KK, Riper H. Effectiveness of a transdiagnostic individually tailored Internet-based and mobile-supported intervention for the indicated prevention of depression and anxiety (ICare Prevent) in dutch college students: study protocol for a randomised controlled trial. Trials. 2018;19(1):1–13. doi: 10.1186/s13063-018-2477-y.
    1. Bouter DC, Zarchev M, de Neve-Enthoven N, Ravensbergen SJ, Kamperman AM, Hoogendijk W, Grootendorst-van Mil NH. A longitudinal study of mental health in at-risk adolescents before and during the COVID-19 pandemic. Eur Child Adolescent Psychiatry Adv Online Publ. 2022 doi: 10.1007/s00787-021-01935-y.
    1. Brunwasser SM, Gillham JE, Kim ES. A meta-analytic review of the penn resiliency program's effect on depressive symptoms. J Consult Clin Psychol. 2009;77(6):1042–1054. doi: 10.1037/a0017671.
    1. Caldas, J. M. European Framework for Action on Mental Health and wellbeing [Final Conference]. EU Joint Action on mental health and well being, Brussells, Belgium. 2016.
    1. Calear AL, Christensen H, Mackinnon A, Griffiths KM, O’Kearney R. The YouthMood Project: a cluster randomized controlled trial of an online cognitive behavioral program with adolescents. J Consult Clin Psychol. 2009;77(6):1021–1032. doi: 10.1037/a0017391.
    1. Campbell-Sills L, Stein MB. Psychometric analysis and refinement of the connor-davidson resilience scale (CD-RISC): validation of a 10-item measure of resilience. J Trauma Stress. 2007;20(6):1019–1028. doi: 10.1002/jts.20271.
    1. Chorpita BF, Yim L, Moffitt C, Umemoto LA, Francis SE. Assessment of symptoms of DSM-IV anxiety and depression in children: a revised child anxiety and depression scale. Behav Res Ther. 2000;38(8):835–855. doi: 10.1016/s0005-7967(99)00130-8.
    1. Clarke GN, Hawkins W, Murphy M, Sheeber LB, Lewinsohn PM, Seeley JR. Targeted prevention of unipolar depressive disorder in an at-risk sample of high school adolescents: a randomized trial of a group cognitive intervention. J Am Acad Child Adolesc Psychiatry. 1995;34(3):312–321. doi: 10.1097/00004583-199503000-00016.
    1. Clarke GN, Hornbrook M, Lynch F, Polen M, Gale J, Beardslee W, O'Connor E, Seeley J. A randomized trial of a group cognitive intervention for preventing depression in adolescent offspring of depressed parents. Arch Gen Psychiatry. 2001;58(12):1127–1134. doi: 10.1001/archpsyc.58.12.1127.
    1. Cobos-Sánchez L, Flujas-Contreras JM, Gómez I. Willingness and action measure for adolescents: psychometric validation in Spanish adolescents. J Contextual Behav Sci. 2020;15:46–51. doi: 10.1016/j.jcbs.2019.11.006.
    1. Cohen J. Statistical power analysis for the behavioral sciences. 2. Hillsdale, NJ: Lawrence Erlbaum Associates, Publishers; 1988.
    1. Connor KM, Davidson JR. Development of a new resilience scale: the connor-davidson resilience scale (CD-RISC) Depress Anxiety. 2003;18(2):76–82. doi: 10.1002/da.10113.
    1. Copeland WE, Shanahan L, Costello EJ, Angold A. Childhood and adolescent psychiatric disorders as predictors of young adult disorders. Arch Gen Psychiatry. 2009;66(7):764–772. doi: 10.1001/archgenpsychiatry.2009.85.
    1. Cunningham JA, Kypri K, McCambridge J. Exploratory randomized controlled trial evaluating the impact of a waiting list control design. BMC Med Res Methodol. 2013;13:150. doi: 10.1186/1471-2288-13-150.
    1. Ehrenreich-May J, Kennedy SM, Sherman JA, Bilek EL, Buzzella BA, Bennett SM, Barlow DH. The unified protocol for transdiagnostic treatment of emotional disorders in adolescents (UP-A; in unified protocols for transdiagnostic treatment of emotional disorders in children and adolescents) New York: Oxford University Press; 2018.
    1. Ehrenreich-May J, Kennedy SM, editors. Applications of the unified protocols for transdiagnostic treatment of emotional disorders in children and adolescents. New York: Oxford University Press; 2021.
    1. Erskine HE, Moffitt TE, Copeland WE, Costello EJ, Ferrari AJ, Patton G, Degenhardt L, Vos T, Whiteford HA, Scott JG. A heavy burden on young minds: the global burden of mental and substance use disorders in children and youth. Psychol Med. 2015;45(7):1551–1563. doi: 10.1017/S0033291714002888.
    1. Fajardo Bullón F, León del Barco B, Felipe Castaño E, Ribeiro Dos Santos EJ. Salud mental en el grupo de edad 4–15 años a partir de los resultados de la Encuesta Nacional de Salud 2006. Rev Esp Salud Publica. 2012;86:445–451.
    1. Faltinsen E, Todorovac A, Hróbjartsson A, Gluud C, Kongerslev MT, Simonsen E, Storebø OJ. Placebo, usual care and wait-list interventions for all mental health disorders. Cochrane Database Syst Rev. 2019 doi: 10.1002/14651858.MR000050.
    1. Fegert JM, Vitiello B, Plener PL, Clemens V. Challenges and burden of the Coronavirus 2019 (COVID-19) pandemic for child and adolescent mental health: a narrative review to highlight clinical and research needs in the acute phase and the long return to normality. Child Adolescent Psychiatry Mental Health. 2020 doi: 10.1186/s13034-020-00329-3.
    1. Feiss R, Dolinger SB, Merritt M, Reiche E, Martin K, Yanes JA, Thomas CM, Pangelinan M. A systematic review and meta-analysis of school-based stress, anxiety, and depression prevention programs for adolescents. J Youth Adolesc. 2019;48(9):1668–1685. doi: 10.1007/s10964-019-01085-0.
    1. Fisak BJ, Jr, Richard D, Mann A. The prevention of child and adolescent anxiety: a meta-analytic review. Prev Sci Off J Soc Prev Res. 2011;12(3):255–268. doi: 10.1007/s11121-011-0210-0.
    1. Fonseca Pedrero E, Pérez Álvarez M, Al-Halabí Díaz S, Inchausti Gómez F, López Navarro E, Muñiz Fernández J, Montoya Castilla I. Tratamientos psicológicos empíricamente apoyados para la infancia y adolescencia: estado de la cuestión. Psicothema. 2021;33(3):386–398. doi: 10.7334/psicothema2021.56.
    1. Furukawa TA, Noma H, Caldwell DM, Honyashiki M, Shinohara K, Imai H, Chen P, Hunot V, Churchill R. Waiting list may be a nocebo condition in psychotherapy trials: a contribution from network meta-analysis. Acta Psychiatr Scand. 2014;130(3):181–192. doi: 10.1111/acps.12275.
    1. Gálvez Casas A, Rosa Guillamón A, García-Cantó E, Rodríguez García PL, Pérez-Soto JJ, Tarraga Marcos L, Tarraga López P. Estado nutricional y calidad de vida relacionada con la salud en escolares del sureste español. Nutr Hosp. 2014;31(2):737–743. doi: 10.3305/nh.2015.31.2.8468.
    1. Garaigordobil M. Cyberbullying: screening de acoso entre iguales. Madrid: Tea; 2013.
    1. Garaigordobil M. Cyberbullying screening de acoso entre iguales descripción datos psicométricos. Int J Develop Edu Psychol. 2014;4(1):311–318.
    1. Garber J. Depression in children and adolescents: linking risk research and prevention. Am J Prev Med. 2006;31(6 Suppl 1):S104–S125. doi: 10.1016/j.amepre.2006.07.007.
    1. Garber J, Weersing VR. Comorbidity of anxiety and depression in youth: implications for treatment and prevention. Clin Psychol Publ Division Clin Psychol Am Psychol Assoc. 2010;17(4):293–306. doi: 10.1111/j.1468-2850.2010.01221.x.
    1. García-Escalera J, Chorot P, Sandín B, Ehrenreich-May J, Prieto A, Valiente RM. An open trial applying the unified protocol for transdiagnostic treatment of emotional disorders in adolescents (UP-A) adapted as a school-based prevention program. In Child Youth Care Forum. 2019 doi: 10.1007/s10566-018-9471-0.
    1. García-Lopez, LJ. Impact of pandemic and aftermath on resilience of young people in the era of Coronavirus. In M.L. Grande-Gascón and J.M. de Faramiñán, Impact of Covid-19 in Jaen analyses and recommendations. Jaen: Institute of advanced studies. 2022.
    1. Gearing RE, Schwalbe CSJ, Lee R, Hoagwood KE. The effectiveness of booster sessions in CBT treatment for child and adolescent mood and anxiety disorders. Depress Anxiety. 2013;30(9):800–808. doi: 10.1002/da.22118.
    1. Ghandour RM, Sherman LJ, Vladutiu CJ, Ali MM, Lynch SE, Bitsko RH, Blumberg SJ. Prevalence and treatment of depression, anxiety, and conduct problems in US children. J Pediatr. 2019;206:256–267. doi: 10.1016/j.jpeds.2018.09.021.
    1. González-Carrasco M, Casas F, Malo S, Viñas F, Dinisman T. Changes with age in subjective well-being through the adolescent years: differences by gender. J Happiness Stud. 2017;18(1):63–88. doi: 10.1007/s10902-016-9717-1.
    1. Goodman R. The strengths and difficulties questionnaire: a research note. J Child Psychol Psychiatry. 1997;38(5):581–586. doi: 10.1111/j.1469-7610.1997.tb01545.x.
    1. Goodman R, Ford T, Simmons H, Gatward R, Meltzer H. Using the strengths and difficulties questionnaire (SDQ) to screen for child psychiatric disorders in a community sample. British J Psychiatry: J Mental Sci. 2000;177:534–539. doi: 10.1192/bjp.177.6.534.
    1. Gratz KL, Roemer L. Multidimensional assessment of emotion regulation and dysregulation: development, factor structure, and initial validation of the difficulties in emotion regulation scale. J Psychopathol Behav Assess. 2004;26(1):41–54. doi: 10.1023/B:JOBA.0000007455.08539.94.
    1. Greco, L. A Murrell, A.M, and Coyne, L.W. (2004). Willingness and acceptance measure for children and adolescents (WAM-C/A). available from laurie greco, division of adolescent medicine and Behavioral Science, Vanderbilt University Medical Center, Nashville, TN.
    1. Guessoum SB, Lachal J, Radjack R, Carretier E, Minassian S, Benoit L, Moro MR. Adolescent psychiatric disorders during the COVID-19 pandemic and lockdown. Psychiatry Res. 2020;291:113264. doi: 10.1016/j.psychres.2020.113264.
    1. Herrero R, Mira A, Cormo G, Etchemendy E, Baños R, García-Palacios A, Ebert DD, Franke M, Berger T, Schaub MP, Görlich D, Jacobi C, Botella C. An Internet based intervention for improving resilience and coping strategies in university students: study protocol for a randomized controlled trial. Internet Interv. 2019;16:43–51. doi: 10.1016/j.invent.2018.03.005.
    1. Hervás G, Jódar R. Adaptación al castellano de la Escala de Dificultades en la Regulación Emocional. Clínica y salud. 2008;19(2):139–156.
    1. Hugh-Jones S, Beckett S, Tumelty E, Mallikarjun P. Indicated prevention interventions for anxiety in children and adolescents: a review and meta-analysis of school-based programs. Eur Child Adolesc Psychiatry. 2021;30(6):849–860. doi: 10.1007/s00787-020-01564-x.
    1. IBM Corp. Released 2021. IBM SPSS Statistics for Windows, Version 28.0. Armonk, NY: IBM Corp IBM SPSS Statistics 28.0 (IBM Corp. Released, 2021)
    1. Instituto Nacional de Estadística. Estadística de migraciones. Provisionales primer semestre 2022 y definitivos 2021. (2021).
    1. James AC, Reardon T, Soler A, James G, Creswell C. Cognitive behavioral therapy for anxiety disorders in children and adolescents. Cochrane Database Syst Rev. 2020;11(11):013162. doi: 10.1002/14651858.CD013162.pub2.
    1. Jané-Llopis E, Hosman C, Jenkins R, Anderson P. Predictors of efficacy in depression prevention programmes. meta-analysis. British J psychiatry J Mental Sci. 2003;183:384–397. doi: 10.1192/bjp.183.5.384.
    1. Jaycox LH, Stein BD, Paddock S, Miles JN, Chandra A, Meredith LS, Tanielian T, Hickey S, Burnam MA. Impact of teen depression on academic, social, and physical functioning. Pediatrics. 2009;124(4):e596–e605. doi: 10.1542/peds.2008-3348.
    1. Kishida K, Hida N, Ishikawa SI. Evaluating the effectiveness of a transdiagnostic universal prevention program for both internalizing and externalizing problems in children: two feasibility studies. Child Adolesc Psychiatry Ment Health. 2022;16(1):1–10. doi: 10.1186/s13034-022-00445-2.
    1. La Greca AM, Ehrenreich-May J, Mufson L, Chan S. Preventing adolescent social anxiety and depression and reducing peer victimization: intervention development and open trial. Child Youth Care Forum. 2016;45(6):905–926. doi: 10.1007/s10566-016-9363-0.
    1. Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD. Assessment of client/patient satisfaction: development of a general scale. Eval Program Plann. 1979;2(3):197–207. doi: 10.1016/0149-7189(79)90094-6.
    1. Larson, C.M. Stories: A revision of the willingness and action measure for children and adolescents (WAM-C/a) [Thesis]. University of North Texas. 2008.
    1. Lawrence PJ, Rooke SM, Creswell C. Review: Prevention of anxiety among at-risk children and adolescents - a systematic review and meta-analysis. Child Adolesc Mental Health. 2017;22(3):118–130. doi: 10.1111/camh.12226.
    1. Loewen OK, Maximova K, Ekwaru JP, Faught EL, Asbridge M, Ohinmaa A, Veugelers PJ. Lifestyle behavior and mental health in early adolescence. Pediatrics. 2019;143(5):11. doi: 10.1542/peds.2018-3307.
    1. Løvaas MES, Lydersen S, Sund AM, Neumer SP, Martinsen KD, Holen S, Reinfjell T. A 12-month follow-up of a transdiagnostic indicated prevention of internalizing symptoms in school-aged children: the results from the EMOTION study. Child Adolescent Psychiatry Mental Health. 2020;14(1):1–13. doi: 10.1186/s13034-020-00322-w.
    1. McEvoy PM, Nathan P, Norton PJ. Efficacy of transdiagnostic treatments: a review of published outcome studies and future research directions. J Cogn Psychother. 2009;23(1):20–33. doi: 10.1891/0889-8391.23.1.20.
    1. Merikangas KR, He JP, Brody D, Fisher PW, Bourdon K, Koretz DS. Prevalence and treatment of mental disorders among US children in the 2001–2004 NHANES. Pediatrics. 2010;125(1):75–81. doi: 10.1542/peds.2008-2598.
    1. Merikangas KR, He JP, Burstein M, Swendsen J, Avenevoli S, Case B, Georgiades K, Heaton L, Swanson S, Olfson M. Service utilization for lifetime mental disorders in US adolescents results of the national comorbidity survey-adolescent supplement (NCS-A) J Am Academy Child Adolescent Psychiatry. 2011 doi: 10.1016/j.jaac.2010.10.006.
    1. Merry SN, Hetrick SE, Cox GR, Brudevold-Iversen T, Bir JJ, McDowell H. Psychological and educational interventions for preventing depression in children and adolescents. Cochrane Database Syst Rev. 2011;12:003380. doi: 10.1002/14651858.CD003380.pub3.
    1. Merry SN, Hetrick SE, Cox GR, Brudevold-Iversen T, Bir JJ, McDowell H. Cochrane review: psychological and educational interventions for preventing depression in children and adolescents. Evidence-Based Child Health Cochrane Rev J. 2012;7(5):1409–1685. doi: 10.1002/ebch.1867.
    1. Mettert K, Lewis C, Dorsey C, Halko H, Weiner B. Measuring implementation outcomes: an updated systematic review of measures psychometric properties. Implementation Res Pract. 2020;1:2633489520936644. doi: 10.1177/2633489520936644.
    1. Muela-Martinez JA, Espinosa-Fernandez L, Garcia-Lopez LJ, Martin-Puga ME. Validation of the structured interview for the assessment of expressed emotion (E5) in a sample of adolescents and young adults from the general population. Frontiers Psychol. 2021;12:723323. doi: 10.3389/fpsyg.2021.723323.
    1. Munder T, Flückiger C, Leichsenring F, Abbass AA, Hilsenroth MJ, Luyten P, Wampold BE. Is psychotherapy effective? A re-analysis of treatments for depression. Epidemiol Psychiatric Sci. 2019;28(3):268–274. doi: 10.1017/S2045796018000355.
    1. Notario-Pacheco B, Solera-Martínez M, Serrano-Parra MD, Bartolomé-Gutiérrez R, García-Campayo J, Martínez-Vizcaíno V. Reliability and validity of the Spanish version of the 10-item connor-davidson resilience scale (10-item CD-RISC) in young adults. Health Qual Life Outcomes. 2011;9:63. doi: 10.1186/1477-7525-9-63.
    1. Ortuño-Sierra J, Fonseca-Pedrero E, Paíno M, Aritio-Solana R. Prevalence of emotional and behavioral symptomatology in Spanish adolescents. Revista de psiquiatria y salud mental. 2014;7(3):121–130. doi: 10.1016/j.rpsm.2013.12.003.
    1. Pachankis JE. A transdiagnostic minority stress treatment approach for gay and bisexual men's syndemic health conditions. Arch Sex Behav. 2015;44(7):1843–1860. doi: 10.1007/s10508-015-0480-x.
    1. Piqueras JA, Gomez-Gomez M, Marzo JC, Gomez-Mir P, Falco R, Valenzuela B. PSICORECUR-SOS COVID-19 studygroup correction to validation of the spanish version of fear of COVID-19 scale its association with acute stress and coping. Int J Mental Health Addict Adv Online Publ. 2021 doi: 10.1007/s11469-021-00703-y.
    1. Piqueras JA, Pineda D, Martin-Vivar M, Sandín B. confirmatory factor analysis and psychometric properties of the revised child anxiety and depression Scale−30 (RCADS-30) in clinical and non-clinical samples. Revista De Psicopatología y Psicología Clínica. 2017;22(3):183–196. doi: 10.5944/rppc.vol.22.num.3.2017.19332.
    1. Polanczyk GV, Salum GA, Sugaya LS, Caye A, Rohde LA. Annual research review: a meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. J Child Psychol Psychiatry. 2015;56(3):345–365. doi: 10.1111/jcpp.12381.
    1. Power E, Hughes S, Cotter D, Cannon M. Youth mental health in the time of COVID-19. Irish J of Psychol Med. 2020;37(4):301–305. doi: 10.1017/ipm.2020.84.
    1. Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, Griffey R, Hensley M. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011;38(2):65–76. doi: 10.1007/s10488-010-0319-7.
    1. Racine N, McArthur BA, Cooke JE, Eirich R, Zhu J, Madigan S. Global prevalence of depressive and anxiety symptoms in children and adolescents during COVID-19: a meta-analysis. JAMA Pediatr. 2021;175(11):1142–1150. doi: 10.1001/jamapediatrics.2021.2482.
    1. Rasing S, Creemers D, Janssens J, Scholte R. Depression and anxiety prevention based on cognitive behavioral therapy for at-risk adolescents: a meta-analytic review. Front Psychol. 2017;8:1066. doi: 10.3389/fpsyg.2017.01066.
    1. Ravens-Sieberer U, Erhart M, Rajmil L, Herdman M, Auquier P, Bruil J, Kilroe J. Reliability, construct and criterion validity of the KIDSCREEN-10 score: a short measure for children and adolescents’ well-being and health-related quality of life. Qual Life Res. 2010;19(10):1487–1500. doi: 10.1007/s11136-010-9706-5.
    1. Ravens-Sieberer U, Gosch A, Abel T, Auquier P, Bellach BM, Bruil J, Rajmil L. Quality of life in children and adolescents: a European public health perspective. Sozial-und Präventivmedizin. 2001;46(5):294–302. doi: 10.1007/BF01321080.
    1. Reef J, Diamantopoulou S, van Meurs I, Verhulst F, van der Ende J. Child to adult continuities of psychopathology: a 24-year follow-up. Acta Psychiatr Scand. 2009;120(3):230–238. doi: 10.1111/j.1600-0447.2009.01422.x.
    1. Sandín B, Valiente RM, Chorot P. RCADS: evaluación de los síntomas de los trastornos de ansiedad y depresión en niños y adolescentes. Revista de Psicopatología y Psicología Clínica. 2009;14(3):193–206. doi: 10.5944/rppc.vol.14.num.3.2009.4078.
    1. Sandín B, Chorot P, Valiente RM, Chorpita BF. Desarrollo de una versión de 30 items de la revised child anxiety and depression scale. Revista De Psicopatología Y Psicología Clínica. 2010;15(3):165–178. doi: 10.5944/rppc.vol.15.num.3.2010.4095.
    1. Sandín B, Chorot P, Valiente RM. Transdiagnóstico: Nueva frontera en psicología clínica. Revista de Psicopatología y Psicología Clínica. 2012;17:185–203. doi: 10.5944/rppc.vol.17.num.3.2012.11839.
    1. Santomauro DF, Mantilla-Herrera AM, Shadid J, Zheng P, Ashbaugh C, Pigott DM, Abbafati C, Adolph C, Amlag JO, Aravkin AY, Bang-Jensen BL, Gregory J, Bertolacci GJ, Bloom SS, Castellano R, Castro E, Chakrabarti S, Chattopadhyay J, Cogen RM, Collins JK, Dai X. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021;398(10312):1700–1712. doi: 10.1016/S0140-6736(21)02143-7.
    1. Sauer-Zavala S, Tirpak JW, Eustis EH, Woods BK, Russell K. Unified protocol for the transdiagnostic prevention of emotional disorders: evaluation of a brief, online course for college freshmen. Behav Ther. 2021;52(1):64–76. doi: 10.1016/j.beth.2020.01.010.
    1. Schmitt JC, Valiente RM, García-Escalera J, Arnáez S, Espinosa V, Sandín B, Chorot P. Prevention of depression and anxiety in subclinical adolescents: effects of a transdiagnostic internet-delivered CBT Program. Int J Environ Res Public Health. 2022;19(9):5365. doi: 10.3390/ijerph19095365.
    1. Seeley JR, Stice E, Rohde P. Screening for depression prevention: identifying adolescent girls at high risk for future depression. J Abnorm Psychol. 2009;118(1):161–170. doi: 10.1037/a0014741.
    1. Solmi M, Radua J, Olivola M, Croce E, Soardo L, Salazar de Pablo G, Fusar-Poli P. Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies. Mol Psychiatry. 2021 doi: 10.1038/s41380-021-01161-7.
    1. Spanish Statistical Office (INE) 2021. Census ministry of economic affairs and digital transformation madrid.
    1. Stice E, Shaw H, Bohon C, Marti CN, Rohde P. A meta-analytic review of depression prevention programs for children and adolescents: factors that predict magnitude of intervention effects. J Consult Clin Psychol. 2009;77(3):486–503. doi: 10.1037/a0015168.
    1. Stockings EA, Degenhardt L, Dobbins T, Lee YY, Erskine HE, Whiteford HA, Patton G. Preventing depression and anxiety in young people: a review of the joint efficacy of universal, selective and indicated prevention. Psychol Med. 2016;46(1):11–26. doi: 10.1017/S0033291715001725.
    1. Stone LL, Otten R, Engels RC, Vermulst AA, Janssens JM. Psychometric properties of the parent and teacher versions of the strengths and difficulties questionnaire for 4- to 12-year-olds: a review. Clin Child Fam Psychol Rev. 2010;13(3):254–274. doi: 10.1007/s10567-010-0071-2.
    1. Teubert D, Pinquart M. A meta-analytic review on the prevention of symptoms of anxiety in children and adolescents. J Anxiety Disord. 2011;25(8):1046–1059. doi: 10.1016/j.janxdis.2011.07.001.
    1. Van Balkom AJ, van Boeijen CA, Boeke AJ, van Oppen P, Kempe PT, van Dyck R. Comorbid depression, but not comorbid anxiety disorders, predicts poor outcome in anxiety disorders. Depress Anxiety. 2008;25(5):408–415. doi: 10.1002/da.20386.
    1. Vázquez FL, Torres A, Otero P, Blanco V, Attkisson CC. Psychometric properties of the castilian spanish version of the client satisfaction questionnaire (CSQ-8) Curr Psychol. 2019;2019(38):829–835. doi: 10.1007/s12144-017-9659-8.
    1. Verboom CE, Sijtsema JJ, Verhulst FC, Penninx BW, Ormel J. Longitudinal associations between depressive problems, academic performance, and social functioning in adolescent boys and girls. Dev Psychol. 2014;50(1):247–257. doi: 10.1037/a0032547.
    1. Voltas N, Hernández-Martínez C, Arija V, Canals J. Suicidality in a community sample of early adolescents: a three-phase follow-up study. Archiv Suicide Res Off J Int Academy Suicide Res. 2020;24(sup2):S217–S235. doi: 10.1080/13811118.2019.1588816.
    1. Weisel KK, Zarski AC, Berger T, Krieger T, Schaub MP, Moser C, Ebert TDD. Efficacy and cost-effectiveness of guided and unguided internet-and mobile-based indicated transdiagnostic prevention of depression and anxiety (ICare Prevent): a three-armed randomized controlled trial in four European countries. Internet Interv. 2019;16:52–64. doi: 10.1016/j.invent.2018.04.002.
    1. Weitkamp K, Seiffge-Krenke I. The association between parental rearing dimensions and adolescent psychopathology: a cross-cultural study. J Youth Adolesc. 2019;48(3):469–483. doi: 10.1007/s10964-018-0928-0.
    1. Werner-Seidler A, Perry Y, Calear AL, Newby JM, Christensen H. School-based depression and anxiety prevention programs for young people: a systematic review and meta-analysis. Clin Psychol Rev. 2017;51:30–47. doi: 10.1016/j.cpr.2016.10.005.
    1. Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, Vos T. Global burden of disease attributable to mental and substance use disorders: findings from the global burden of disease study 2010. Lancet. 2013;382(9904):1575–1586. doi: 10.1016/S0140-6736(13)61611-6.
    1. Wilamowska ZA, Thompson-Hollands J, Fairholme CP, Ellard KK, Farchione TJ, Barlow DH. Conceptual background, development, and preliminary data from the unified protocol for transdiagnostic treatment of emotional disorders. Depress Anxiety. 2010;27(10):882–890. doi: 10.1002/da.20735.
    1. Wierzbicki M, Pekarik G. A meta-analysis of psychotherapy dropout. Prof Psychol Res Pract. 1993;24(2):190. doi: 10.1037/0735-7028.24.2.190.
    1. World Health Organization (WHO). mhGAP Intervention Guide - Version 2.0. WHO press. 2016.
    1. World Health Organization (WHO) (2021). Depression. .

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe